Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion

Endocrine Reviews

Volumn 16, Issue 3, 1995, Pages 322-353

  Ehrmann, David A ^a,b   Barnes, Randall B ^a,c   Rosenfield, Robert L ^a,b,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b Departments of Preventive Medicine   (United States)

^c Department of Obstetrics   (United States)

^d Departments of Pediatrics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RELEASE; ENZYME ACTIVITY; GRANULOSA CELL; HORMONAL REGULATION; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HYPERANDROGENISM; INSULIN RELEASE; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; STEROIDOGENESIS; THECA CELL; VIRILIZATION;

ANDROGENS; FEMALE; HUMAN; HYPERANDROGENISM; OVARIAN DISEASES; POLYCYSTIC OVARY SYNDROME; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 85047696604     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.16.3.322     Document Type: Article

References (397)

1. Stein IF, Leventhal ML 1935 Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181-191
2. Culiner A, Shippel S 1949 Virilism and theca cell hyperplasia of the polycystic ovary syndrome. J Obstet Gynaecol Br Commonw 56:439-435
3. Goldzieher MW, Green JA 1962 The polycystic ovary. I. Clinical and histologic features. J Clin Endocrinol Metab 22:325-338
4. Hughesdon PE 1982 Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called “hyperthecosis,”. Obstet Gynecol Surv 37:59-77
5. Judd HL, Scully RE, Herbst AI, Yen SS, Ingersol FM, Kliman B 1973 Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease. Am J Obstet Gynecol 117:976-982
6. Kim MH, Rosenfield RL, Hosseinian AH, Schneir HG 1979 Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries. Am J Obstet Gynecol 134:445-452
7. Yen SSC, Vela P, Rankin J 1970 Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab 30:435-442
8. Hatch R, Rosenfield RL, Kim MH, Tredway D 1981 Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140:815-830
9. Conway GS, Honour JW, Jacobs HS 1989 Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 30:459-470
10. Franks S 1989 Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf) 31:87-120
11. Gadir AA, Khatim MS, Mowafi RS, Alnaser HMI, Alzaid HGN, Shaw RW 1991 Polycystic ovaries: do these represent a specific endocrinopathy? Br J Obstet Gynaecol 98:300-305
12. Futterweit W, Krieger DT 1979 Pituitary tumors associated with hyperprolactinemia and polycystic ovary disease. Fertil Steril 31: 608-613
13. Dewailly D, Vantyghem-Haudiquet MC, Sainsard C, Buvat J, Cappoen JP, Ardaens K, Racadot A, Lefebvre J, Fossati P 1986 Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. J Clin Endocrinol Metab 63:418-423
14. Levin JH, Carmina E, Lobo RA 1991 Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia? Fertil Steril 56:635-640
15. Dunaif A, Scully RE, Andersen RN, Chapin DS, Crowley Jr WF 1984 The effects of continuous androgen secretion on the hypothalamic-pituitary axis in women: evidence from a luteinized thecoma of the ovary. J Clin Endocrinol Metab 59:389-393
16. Givens JR, Andersen RN, Wiser WL, Donelson AJ, Coleman SA A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease. J Clin Endocrinol Metab 41:845-853
17. Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, Meade TW 1992 How common are polycystic ovaries in normal women and what is their significance for the fertility of the population. Clin Endocrinol (Oxf) 37:127-134
18. Chang RJ, Nakamura RM, Judd HL, Kaplan SA 1983 Insulin resistance in nonobese patients with polycystic ovary syndrome. J Clin Endocrinol Metab 57:356-359
19. Stewart PM, Beastall GM, Shackleton CHI, Edwards CRE 1990 5a-reductase activity in polycystic ovary syndrome. Lancet 1: 431-433
20. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
21. Abraham GE, Maroulis GB, Buster JE, Chang RJ, Marshall JR Effect of dexamethasone on serum cortisol and androgen levels in hirsute patients. Obstet Gynecol 47:395-402
22. Berger MJ, Taymor ML, Patton WC 1975 Gonadotropin levels and secretory patterns in patients with typical and atypical polycystic ovarian disease. Fertil Steril 26:619-626
23. Adams J, Poison DW, Franks S 1986 Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J [Clin Res] 293:355-359
24. Hull MGR 1987 Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1:235-245
25. Barnes R, Rosenfield RL 1989 The polycystic ovary syndrome: pathogenesis and treatment. Ann Intern Med 110:386-399
26. Barbieri RL, Smith S, Ryan KJ 1988 The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 50: 197-212
27. Kirschner MA, Zucker IR, Jesperson D 1976 Idiopathic hirsut-ism-an ovarian abnormality. N Engl J Med 294:637-640
28. Wajchenberg BL, Achando A, Okada H, Czeresnia CE, Peixoto S, Lima SS, Goldman J 1986 Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test. J Clin Endocrinol Metab 63:1204-1210
29. Ehrmann DA, Rosenfield RL, Barnes RB, Sheikh Z, Functional correlates of ovarian structure in hyperandrogenic women. Program of the 74th Annual Meeting of The Endocrine Society, San Antonio TX, 1992
30. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327:157-162
31. deZiegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, Chang RJ 1989 Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovary disease. J Clin Endocrinol Metab 68: 1111-1115
32. Dunaif A, Green G, Futterweit W, Dobrjansky A 1990 Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 70:699-704
33. Rittmaster RS, Thompson DI 1990 Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab 70:1096-1102
34. Lachelin GCL, Judd HL, Swanson SC, Hauch ME, Parker DC, Yen SSC 1982 Long term effects of nightly dexamethasone administration in patients with polycystic ovarian disease. J Clin Endocrinol Metab 55:768-773
35. Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA 1989 Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 320:559-565
36. Rosenfield RL, Barnes RB, Cara JF, Lucky AW 1990 Dysregulation of cytochrome P450cl la as the cause of polycystic ovary syndrome. Fertil Steril 53:785-791
37. Merrill JA 1963 The morphology of the prepubertal ovary: relationship to the polycystic ovary syndrome. South Med J 56:225-231
38. Zumoff B, Freeman R, Coupey S, Saenger P, Markowitz M, Kream J 1983 A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic ovary syndrome. N Engl J Med 309:1206-1209
39. Moll Jr GW, Rosenfield RL 1983 Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr 102: 461-464
40. Porcu E, Venturoli S, Magrini O, Bolzani R, Gabbi D, Paradisi R, Fabbri R, Flamigni C 1987 Circadian variations of luteinizing hormone can have two different profiles in adolescent anovulation. J Clin Endocrinol Metab 65:488-493
41. Emans SJ, Grace E, Woods ER, Mansfield J, Crigler Jr JF 1988 Treatment with dexamethasone of androgen excess in adolescent patients. J Pediatr 112:821-826
42. Goodpasture JC, Ghai K, Cara JF, Rosenfield RL 1993 Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girls. Clin Obstet Gynecol 36:773-785
43. Ibanez L, Potau N, Virdis R, Zanpolli M, Terzi C, Gussinye M, Carrascosca A, Vicens-Calvet E1993 Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1599-1603
44. Apter D, Biitzow T, Laughlin GA, Yen SSC 1994 Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab 79:119-125
45. Haymond MW, Bussmann Y, Wiest WG 1979 Elevated free testosterone in an obese, hirsute, premenarchial girl: effects of nore-thynodrel and mestranol. Pediatrics 64:609-612
46. Rao JK, Chihal HJ, Johnson CM 1985 Primary polycystic ovary syndrome in a premenarcheal girl. J Reprod Med 30:361-364
47. Declercq JA, van de Calseyde JF 1977 Polycystic ovarian disease: diagnosis, frequency and symptoms in a general gynecological practice. Br J Obstet Gynaecol 84:380-385
48. Sommers SC, Wadman P 1956 Pathogenesis of polycystic ovaries. Am J Obstet Gynecol 72:160-169
49. Nobels F, Dewailly D 1992 Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril 58:655-666
50. Polhemus DW 1953 Ovarian maturation and cyst formation in children. Pediatrics 11:588-593
51. Apter D, Vihko R 1985 Hormonal patterns of the first menstrual cycles. In: Flamigni C, et al (eds) Adolescence in Females. Year Book Medical Publishers, Chicago, pp 215-238
52. Siegberg R, Nilsson CG, Stenman U-H, Widholm O 1986 Endocrinologic features of oligomenorrheic adolescent girls. Fertil Steril 46:852-857
53. Venturoli S, Porcu E, Fabbri R, Paradisi R, Ruggeri S, Bolelli G, Orsini LF, Gabbi D, Flamigni C 1986 Menstrual irregularities in adolescents: hormonal pattern and ovarian morphology. Horm Res 24:269-279
54. Venturoli S, Porcu E, Fabbri R, Magrini O, Gammi L, Paradisi R, Flamigni C 1992 Longitudinal evaluation of the different gonadotropin pulsatile patterns in anovulatory cycles of young girls. J Clin Endocrinol Metab 74:836-841
55. Cistemino M, Pasquino AM, Bozzola M, Balducci R, Lorini R, Pucarelli I, Segni M, Severi F 1992 Final height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate. Horm Res 37:86-90
56. Root AW, Moshang Jr T 1984 Evolution of the hyperandrogenism/polycystic ovarian syndrome from isosexual precocious puberty: report of two cases. Am J Obstet Gynecol 149:763-767
57. Cooper HE, Spellacy WN, Prem KA, Cohen WD 1968 Hereditary factors in the Stein-Leventhal syndrome. Am J Obstet Gynecol 100:371-387
58. Wilroy RS, Givens JR, Wiser WL, Coleman SA, Andersen RN, Fish SA 1975 Hyperthecosis: an inheritable form of polycystic ovarian disease. Birth Defects 11:81-85
59. Hague WM, Adams J, Reeders ST, Peto TEA, Jacobs HS 1988 Familial polycystic ovaries: a genetic disease? Clin Endocrinol (Oxf) 29:593-605
60. McDonough PG, Mahesh VB, Ellegood JO 1972 Steroid, follicle-stimulating hormone and luteinizing hormone profiles in identical twins with polycystic ovaries. Am J Obstet Gynecol 113:1072-1076
61. Ferriman D, Purdie AW 1979 The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol (Oxf) 11:291-300
62. Carey AH, Chan KL, Short F, White D, Williamson R, Franks S 1993 Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 38:653-658
63. Hague WM, Adams J, Rodda C, Brook CG, de Bruyn R, Grant DB, Jacobs HS 1990 The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) 33:501-510
64. Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S, Williamson R 1994 Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP 17. Hum Mol Genet 3:1873-1876
65. Moller DE, Flier J 1988 Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (Type A insulin resistance). N Engl J Med 319:1526-1529
66. Kadawaki T, Berins C, Cama A 1988 Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240:787-790
67. Accili D, Frapier C, Mosthat L, McKeon C, Elbein SC, Permutt MA 1989 A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes. EMBO J 8:2509-2517
68. Moller DE, Flier JS 1991 Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 325:938-948
69. Krook A, Kumar S, Laing I, Boulton AJM, Wass JAH, O’Rahilly OS 1994 Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 43:357-368
70. Moller DE, Cohen O, Yamaguchi Y, Assiz R, Grigorescu F, Eberle A, Morrow LA, Moses AC, Flier JS 1994 Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 43:247-255
71. Elders MJ, Schedewie HK, Olefsky J, Givens B, Char F, Bier DM, Baldwin D, Fiser RH, Seyedabadi S, Rubenstein A 1982 Endocrine-metabolic relationships in patients with leprechaunism. J Natl Med Assoc 74:1195-1210
72. McKenna TJ 1988 Current concepts: pathogenesis and treatment of polycystic ovary syndrome. N Engl J Med 318:558-562
73. King RJB, Mainwaring WIP 1974 Steroid-Cell Interactions. University Park Press, Baltimore, pp 220-241
74. Billiar RB, Richardson D, Anderson E, Mahajan D, Little B 1985 The effect of chronic and acyclic elevation of circulating andro-stenedione or estrone concentrations on ovarian function in the rhesus monkey. Endocrinology 116:2209-2220
75. Richardson DW, Gordon K, Billiar RB, Little AB 1992 Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action. Endocrinology 130: 1090-1096
76. Chang RJ, Manfdel FP, Lu JK, Judd HL 1982 Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. J Clin Endocrinol Metab 54:490-494
77. Dunaif A, Longcope C, Canick J, Badger T, Crowley Jr WF 1985 The effects of the aromatase inhibitor deltal-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease. J Clin Endocrinol Metab 60:773-780
78. McKenna TJ, Cunningham SK 1992 Adrenal abnormalities in polycystic ovary syndrome and the impact of their correction. In: Dunaif A, Givens J, Haseltine F, Merriam G (eds) Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Blackwell Scientific, Cambridge, MA, pp 183-193
79. Karpas AE, Rodriguez-Rigau LJ, Smith KD, Steinberger E 1984 Effect of acute and chronic androgen suppression by glucocorticoids on gonadotropin levels in hirsute women. J Clin Endocrinol Metab 59:780-784
80. Abraham GE 1974 Ovarian and adrenal contributions to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 39:340-346
81. Mastorakos G, Webster EL, Friedman TC, Chrousos GC 1993 Immunoreactive corticotropin-releasing hormone (CRH) and its binding sites in the rat ovary. J Clin Invest 92:961-968
82. Mastorakos G, Scopa CD, Vryonidou A, Friedman TC, Kattis D, Phenekos C, Merino MJ, Chrousos GP 1994 Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J Clin Endocrinol Metab 79:1191-1197
83. Erickson GF, Hsueh AJ, Quigley ME, Rebar RW, Yen SS 1979 Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab 49: 514-519
84. Erickson GF 1992 Folliculogenesis in polycystic ovary syndrome. In: Dunaif A, Givens J, Haseltine F, Merriam G (eds) Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Blackwell Scientific, Cambridge, MA
85. Billig H, Furuta I, Hsueh AJW 1993 Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 133: 2204-2212
86. Hsueh AJW, Billig H, Tsafiri A 1994 Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 15:707-724
87. Hillier S, Ross GT 1979 Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. Biol Reprod 20:261-268
88. Hoffman F, Meger C 1965 On the action of intraovarian injection of androgen on follicle and corpus luteum maturation in women. Geburtsh Frauenheilk 25:1132-1137
89. Schreiber JR, Reed R, Ross GT 1976 A receptor-like testosterone-binding protein in ovaries from estrogen-stimulated hypophysectomized immature female rats. Endocrinology 98:1206-1213
90. Uilenbroek JTJ, Woutersen PJA, Van der Schoot P 1980 Atresia in preovulatory follicles: gonadotropin binding in steroidogenic activity. Biol Reprod 23:219-229
91. Louvet JP, Harman SM, Schreiber JR, Ross GT 1975 Evidence for a role of androgens in follicular maturation. Endocrinology 97: 366-372
92. McNatty KP, Baird DT 1978 Relationship between follicle stimulating hormone, androstenedione and estradiol in human follicular fluid. J Endocrinol 76:527-531
93. McNatty KP, Makris A, Reinhold VN, DeGrazia C, Osathanondh R, Ryan KJ 1979 Metabolism of androstenedione by human ovarian tissues in vitro with particular reference to 5a-reductase and aromatase activity. Steroids 34:429-434
94. McNatty KP, Smith DM, Makris A, Osathanondh R, Ryan KJ 1979 The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 49:851-860
95. Franks S 1992 Morphology of the polycystic ovary. In: Dunaif A, Givens J, Haseltine F, Merriam G (eds) Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Black, well Scientific, Cambridge, MA
96. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C 1985 The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 6:371-399
97. Futterweit W, Deligdisch L 1986 Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 62:16-21
98. Spinder T, Spijkstra JJ, Van Den Tweel, Burger CW, Van Kessel H, Hompes PG, Gooren LJ 1989 The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab 69:151-156
99. Pache TD, Hop WCJ, de Jong FH, Leerentveld RA, Van Geldorp H, Van De Camp TM, Gooren LJ, Fauser BC 1992 17β-oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals. Clin Endocrinol (Oxf) 36: 565-571
100. Lucis OJ, Hobkirk R, Hollenberg CH, MacDonald SA, Blahey P 1966 Polycystic ovaries associated with congenital adrenal hyperplasia. Can Med Assoc J 94:1-7
101. Erickson GF, Magoffin DA, Jones KL 1989 Theca function in polycystic ovaries of a patient with virilizing congenital adrenal hyperplasia. Fertil Steril 51:173-176
102. Rosenfield RL, Ehrlich EN, Cleary R 1972 Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women. J Clin Endocrinol 34:92-98
103. Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield SE, Kohn B, Lemer A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, New MI 1981 Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab 53:1193-1198
104. Feldman S, Billaud L, Thalabard J-C, Raux-Demay MC, Mowszowicz I, Kuttenn F, Mauvais-Jarvis P 1992 Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 74:635-639
105. Rheaume E, Lachance Y, Zhao H-F, Breton N, Dumont M, De Launoit Y, Trudel C, Luuthe V, Simard J, Labrie F 1991 Structure and expression of a new complementary DNA encoding the almost exclusive 3 β-hydroxysteroid dehydrogenase/A5-A4-isomerase in human adrenals and gonads. Mol Endocrinol 5:1147-1157
106. Axelrod LR, Goldzieher JW, Ross DS 1965 Concurrent 3β-hydroxysteroid dehydrogenase deficiency in adrenal and sclerocystic ovary. Acta Endocrinol (Copenh) 392-412
107. Rosenfield RL, Rich BH, Wolfsdorf JE, Cassorla F, Parks JS, Bongiovanni AM, Wu CH, Shackelton CH 1980 Pubertal presentation of congenital A5-β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 51:345-353
108. Pang S, Levine LS, Stoner E, Opitz JM, Pollack MS, Dupont B, New MI 1983 Non-salt losing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency with normal glo-merulosa function. J Clin Endocrinol Metab 56:808-818
109. Sanchez R, Rhéaume E, LaFlamme N, Simard J, Rosenfield RL, Labrie F 1994 Detection and functional characterization of the novel missense mutation Y254D in type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene of a female patient with nonsalt-losing 3β-HSD deficiency. J Clin Endocrinol Metab 78:561-567
110. Pang S, Lemer A, Stoner E, Levine LS, Oberfield SE, Engel I, New MI 1985 Late-onset steroid 3/3-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women. J Clin Endocrinol Metab 60:428-436
111. Siegel SF, Finegold DN, Lanes R, Lee PA 1990 ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. N Engl J Med 323:849-854
112. Eldar-Geva T, Hurwitz A, Vecsei P, Palti Z, Milwidsly A, Rosier A 1990 Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia. N Engl J Med 323:855-863
113. Pang S, Softness B, Sweeney W, New MI 1987 Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency. N Engl J Med 316:1295-1301
114. Toscano V, Balducci R, Bianchi P, Mangiantini A, Sciarra F 1990 Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease. J Clin Endocrinol Metab 71:288-292
115. Inkster SE, Brodie AMH 1991 Expression of aromatase cytochrome P-450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study. J Clin Endocrinol Metab 73:717-726
116. Franks S, Mason HD 1991 Polycystic ovary syndrome: interaction of follicle stimulating hormone and polypeptide growth factors in oestradiol production by human granulosa cells. J Steroid Biochem Mol Biol 40:405-409
117. Erickson GF, Garzo VG, Magoffin DA 1989 Insulin-like growth factor I regulates aromatase activity in human granulosa and granulosa luteal cells. J Clin Endocrinol Metab 69:716-724
118. Erickson GF, Magoffin DA, Cragun JR, Chang RJ 1990 The effects of insulin and insulin-like growth factors I and II on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab 70:894-902
119. Shimasaki S, Shimonaka M, Ui M, Inouy S, Shibata F, Ling N 1990 Structural characterization of a follicle-stimulating hormone action inhibitor in porcine ovarian follicular fluid. J Biol Chem 265:2198-2202
120. Brailly S, Gougeon A, Milgrom E, Bomsel-Helmreich O, Pa-piemik E 1981 Androgens and progestins in the human ovarian follicle: differences in the evolution of preovulatory, healthy nonovulatory and atretic follicles. J Clin Endocrinol Metab 53:128-134
121. Hillier SG, van den Boogard AJM, Reichart Jr LE, van Hall EV 1980 Alterations in granulosa cell aromatase activity accompanying preovulatory follicular development in the rat ovary with evidence that 5a-reduced C19 steroids inhibit the aromatase reaction in vitro. J Endocrinol 84:409-419
122. Hillier SG 1987 Intrafollicular paracrine function of ovarian androgen. J Steroid Biochem 27:351-357
123. Haning Jr RV, Hackett RJ, Flood CA, Loughlin JS, Zhao QY, Longcope C 1993 Testosterone, a follicular regulator: key to anovulation. J Clin Endocrinol Metab 77:710-715
124. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER 1994 A syndrome of female pseudohermaphroditism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin En. docrinol Metab 78:1287-1292
125. Richards JS, Jonassen JA, Kersey KA 1980 Evidence that changes in tonic luteinizing hormone secretion determine the growth of preovulatory follicles in the rat. Endocrinology 107:641-648
126. Richards JS, Bogovich K 1982 Effects of human chorionic gonadotropin and progesterone on follicular development in the immature rat. Endocrinology 111:1429-1438
127. Gougeon A 1986 Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1:81-87
128. Kamrava MM, Seibel MM, Berger MJ, Thompson I, Taymor ML 1982 Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low dose follicle-stimulating hormone. Fertil Steril 37:520-523
129. Poison DW, Mason HD, Saldahna MBY, Franks S 1987 Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 26:205-212
130. Poison DW, Mason HD, Kiddy DS 1989 Low-dose follicle-stimulating hormone in the treatment of polycystic ovary syndrome: a comparison of pulsatile subcutaneous with daily intramuscular therapy. Br J Obstet Gynaecol 96:746-748
131. Donderwinkel PFJ, Schoot DC, Coelingh Bennink HJT, Fauser BCJM 1992 Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome. Lancet 340:983
132. Hornnes P, Giroud D, Howies C, Loumaye E 1993 Recombinant human follicle-stimulating hormone treatment leads to normal follicular growth, estradiol secretion, and pregnancy in a World Health Organization group II anovulatory woman. Fertil Steril 60:724-726
133. Keettel WC, Bradbury JT, Stoddard FJ 1957 Observations on the PCO syndrome. Am J Obstet Gynecol 73:954-965
134. MacArthur JW, Ingersall FM, Worcester J 1958 The urinary excretion of interstitial cell and follicle-stimulating hormone activity by women with diseases of the reproductive system. J Clin Endocrinol Metab 18:1202-1215
135. Burger CW, Korsen T, van Kessel H, van Dop PA, Caron FJM, Schoemaker J 1985 Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea. J Clin Endocrinol Metab 61:1126-1132
136. Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C 1988 Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. J Clin Endocrinol Metab 66:327-333
137. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF 1988 Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gondado-troph desensitization. J Clin Endocrinol Metab 66:165-172
138. Venturoli S, Porcu E, Fabbri R, Magrini O, Gammi L, Paradisi R, Forcacci M, Bolzani R, Flamigni C 1988 Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome. Clin Endocrinol (Oxf) 28:93-107
139. Kazer RR, Kessel B, Yen SSC 1987 Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J Clin Endocrinol Metab 65:233-236
140. Hall JE, Whitcomb RW, Rivier JE, Vale WW, Crowley Jr WF 1990 Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free a-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. J Clin Endocrinol Metab 70:328-335
141. Hall JE, Taylor AE, Martin KA, Crowley Jr WF 1992 Neuroendocrine investigation of polycystic ovary syndrome: new approaches. In: Dunaif A, Givens J, Haseltine F, Merriam G (eds) Current issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Blackwell Scientific, Cambridge, MA
142. Berga SL, Guzick DS, Winters SJ 1993 Increased luteinizing hormone and a-subunit secretion in women with hyperandrogenic anovulation. J Clin Endocrinol Metab 77:895-901
143. Haisenleder DJ, Dalkin AC, Ortolano GA, Marshall JC, Shupnik MA 1991 A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo. Endocrinology 128:509-517
144. Soules MR, Clifton DK, Bremne WJ, Steiner RA 1987 Corpus luteum insufficiency induced by rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase. J Clin Endocrinol Metab 65:457-464
145. Christman GM, Randolph JF, Kelch RP, Marshall JC 1991 Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease. J Clin Endocrinol Metab 72:1278-1285
146. Blankstein J, Rabinovici J, Goldenberg M, Shaley J, Mehta A, Serr DM, Mashiach S 1987 Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease. J Clin Endocrinol Metab 65: 1164-1167
147. Quigley ME, Rakoff JS, Yen SS 1981 Increased LH sensitivity to dopamine inhibition in polycystic ovary syndrome. J Clin Endocrinol Metab 52:231-234
148. Cumming DC, Reid RL, Quigley ME, Rebar RW, Yen SSC 1984 Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome. Clin Endocrinol (Oxf) 20:643-648
149. Barnes RB, Lobo RA 1985 Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation. J Clin Endocrinol Metab 61:779-782
150. Barnes RB, Mieleikowsky GN, Cha KY, Spencer CA, Lobo RA 1986 Effects of dopamine and metoclopramide in polycystic ovary syndrome. J Clin Endocrinol Metab 63:506-509
151. Moll Jr GW, Rosenfield RL, van Cauter E, Burstein S 1987 Origin of episodic fluctuations of plasma testosterone in women: adrenal, ovarian, and TeBG contributions. In: Crowley Jr WF, Hofler JG (eds) The Episodic Secretion of Hormones. John Wiley/Churchill Livingstone, New York, pp 403-414
152. Yen SSC, Laughlin GA, Morales AJ 1993 Interface between extra and intraovarian factors in polycystic ovarian syndrome. Ann NY Acad Sci 687:98-111
153. Young JR, Jaffe RB 1976 Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. II. J Clin Endocrinol Metab 42:432-442
154. Chang RJ, Jaffe RB 1978 Progesterone effects on gonadotropin release in women pretreated with estradiol. J Clin Endocrinol Metab 47:119-125
155. March CM, Goebelsmann U, Nakamura RM, Mishell Jr DR 1979 Roles of estradiol and progesterone in eliciting the midcycle luteinizing hormone and follicle-stimulating hormone surges. J Clin Endocrinol Metab 49:507-513
156. Melrose P, Gross L 1987 Steroid effects on the secretory modalities of gonadotropin-releasing hormone release. Endocrinology 121: 190-199
157. Kalra PS, Kalra SP 1982 Discriminative effects of testosterone on hypothalamic luteinizing hormone-releasing hormone levels and luteinizing hormone secretion in castrated male rats: analyses of dose and duration characteristics. Endocrinology 111:24-29
158. Roselli CE, Kelly MJ, Ronnekleiv OK 1990 Testosterone regulates progonadotropin releasing hormone levels in the preoptic area and basal hypothalamus of the male rat. Endocrinology 126:1080-1086
159. Gharib SD, Leung PCK, Carroll RS, Chin WW 1990 androgens positively regulate follicle-stimulating hormone β-subunit mRNA levels in rat pituitary cells. Mol Endocrinol 4:1620-1626
160. Iliff-Sizemore SA, Ortolano GA, Haisenleder DJ, Dalkin AC, Krueger KA, Marshall JC 1990 Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude. Endocrinology 127:2876-2883
161. Kuttenn F, Couillin P, Girard F, Billaud L, Vincens M, Boucek-kine C, Thalabard JC, Maudelonde T, Spritzer P, Mowszowicz I 1985 Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 313:224-231
162. Lobo RA, Goebelsmann U 1982 Effect of androgen excess on inappropriate gonadotropin secretion as found in the polycystic ovary syndrome. Am J Obstet Gynecol 142:394-401
163. Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM 1994 Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 79:1328-1333
164. Nagamani M, Lingold JC, Gomez LG, Garza JR 1981 Clinical and hormonal studies in hyperthecosis of the ovaries. Fertil Steril 36: 326-332
165. Rosenfield RL 1985 Congenital adrenal hyperplasia and reproductive function in females. In: Flamigni C, Venturoli S, Givens J (eds) Adolescence in Females. Year Book Medical Publishers Inc, Chicago, pp 373-387
166. Dunaif A 1986 Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome? J Clin Endocrinol Metab 63:215-221
167. Serafini P, Silva PD, Paulson RJ, Elkind-Hirsch K, Hernandez M, Lobo RA 1986 Acute modulation of the hypothalamic-pituitary axis by intravenous testosterone in normal women. Am J Obstet Gynecol 155:1288-1292
168. Sahin Y, Kelestimur F 1993 17-hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 39:151-155
169. White D, Leigh A, Wilson C, Donaldson A, Franks S 1995 Gonadotrophin and gonadal steroid response to a dose of long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 42:475-481
170. Luppa P, Muller B, Jacob K, Kimmig R, Strowitzki T, Hoss C, Weber MM, Engelhardt D, Lobo RA 1995 Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion. J Clin Endrocrinol Metab 80:280-288
171. Rosenfield RL, Barnes RB, Ehrmann DA 1994 Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotrppin releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 79:1686-1692
172. Barbieri RL 1992 Human ovarian 17-ketosteroid oxidoreductase: unique characteristics of the granulosa-luteal cell and stromal enzyme. Am J Obstet Gynecol 166:1117-1123
173. Rajaniemi HJ, Ronnberg L, Kauppila A, Ylostalo P, Vihko R 1980 Luteinizing hormone receptors in ovarian follicles of patients with polycystic ovarian disease. J Clin Endocrinol Metab 51:1054-1057
174. Bardin CW, Lipsett MB 1967 Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest 46:891-902
175. Longcope C, Pratt JH 1977 Blood production rates of estrogens in women with differing ratios of urinary estrogen conjugates. Steroids 29:483-492
176. Southren AL, Gordon GG, Tochimoto S, Olito J, Sherman DH, Pinzon G 1969 Testosterone and androstenedione metabolism in the polycystic ovary syndrome: studies of the percentage binding of testosterone in plasma. J Clin Endocrinol Metab 29:1356-1363
177. Longcope C, Tait JF 1971 Validity of metabolic clearance and interconversion rates of estrone and 17β-estradiol in normal adults. J Clin Endocrinol Metab 32:481-490
178. Strott CA, Hoshimi T, Lipsett MB 1989 Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia. J Clin Invest 48:930-939
179. Dunn JF, Misula BC, Rodbard D 1981 Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 53:58-68
180. Gilling-Smith C, Willis DS, Beard RW, Franks S 1994 Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 79:1158-1165
181. Mason HD, Willis DS, Holly JMP, Franks S 1994 Insulin preincubation enhances insulin like growth factor-II (IGF-II) action on steroidogenesis in human granulosa cells. J Clin Endocrinol Metab 78:1265-1267
182. McAllister JM, Kerin JFP, Trant JM, Estabrook RW, Mason JI, Waterman MR, Simpson ER 1989 Regulation of cholesterol side-chain cleavage and 17α-hydroxylase/lyase activities in proliferating human theca interna cells in long term monolayer culture. Endocrinology 125:1959-1966
183. Voutilainen R, Tapanainen J, Chung B-C, Matteson KJ, Miller WL 1986 Hormonal regulation of P450 see (20, 22-desmolase) and P450cl7 (17α-hydroxylase/17, 20-lyase) in cultured human granulosa cells. J Clin Endocrinol Metab 63:202-207
184. Anakwe OO, Payne AH 1987 Noncoordinate regulation of de novo synthesis of cytochrome P-450 cholesterol side-chain cleavage and cytochrome P-45017α-hydroxylase/C17-20 lyase in mouse Leydig cell cultures: relation to steroid production. Mol Endocrinol 1: 595-603
185. Dufau M 1988 Endocrine regulation and communicating functions of the Leydig cell. Annu Rev Physiol 50:483-508
186. Dufau MO, Winters CA, Hattori M, Aquilano D, Baranao JL, Nozu K, Baukal A, Catt KJ 1984 Hormonal regulation of androgen production by the Leydig cell. J Steroid Biochem 20:161-173
187. Malaska T, Payne AH 1984 Luteinizing hormone and cyclic AMP-mediated induction of microsomal cytochrome P-450 enzymes in cultured mouse Leydig cells. J Biol Chem 259:11654-11657
188. Chasalow F 1979 Mechanism and control of rat testicular steroid synthesis. J Biol Chem 254:3000-3005
189. Quinn PG, Payne AH 1985 Steroid product-induced, oxygen-mediated damage of microsomal cytochrome P-450 enzymes in Leydig cell cultures. J Biol Chem 260:2092-2099
190. Forest MG, Lecoq A, Saez JM 1979 Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. Plasma 17α-hydroxyprogesterone, A4-androstenedione, estrone, and 17β-estradiol: evidence for the action of human chorionic gonadotropin on intermediate enzymes implicated in steroid biosynthesis. J Clin Endocrinol Metab 49:284-291
191. Smals AGH, Kloppenborg PW, Pieters GFFM, Losekoot DC, Ben-raad TJ 1978 Basal and human chorionic gonadotropin-stimulated 17α-hydroxyprogesterone and testosterone levels in Klinefelter’s syndrome. J Clin Endocrinol Metab 47:1144-1147
192. Saez JM, Forest MG 1979 Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. I. Implications for human chorionic gonadotropin stimulation test. J Clin Endocrinol Metab 49:278-283
193. Kirschner MA, Wider JA, Ross GT 1970 Leydig cell function in men with gonadotropin-producing testicular tumors. J Clin Endocrinol Metab 30:504-511
194. Smals AGH, Pieters GFFM, Kloppenborg PWC, Lozekoot DC, Benraad TJ 1980 Lack of a biphasic steroid response to single human chorionic gonadotropin administration in patients with isolated gonadotropin deficiency. J Clin Endocrinol Metab 50: 879-881
195. Richards JS, Hedin L 1988 Molecular aspects of hormone action in ovarian follicular development, ovulation, and luteinization. Annu Rev Physiol 50:441-463
196. Magoffin DA 1989 Evidence that luteinizing hormone-stimulated differentiation of purified ovarian thecal-interstitial cells is mediated by both type I and type II adenosine 3’, 5’-monophosphate-dependent protein kinases. Endocrinology 125:1464-1473
197. Cara JF, Rosenfield RL 1988 Insulin-like growth factor-I and insulin potentiate luteinizing hormone-induced androgen sythesis by rat ovarian theca-interstitial cells. Endocrinology 123:733-739
198. Cara JF, Fan J, Azzarello J, Rosenfield RL 1990 Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells. J Clin Invest 86:560-565
199. Lamprecht SA, Zor U, Salomon Y, Koch Y, Ahem K, Lindner H 1977 Mechanism of hormonally induced refractoriness of ovarian adenylate cyclase to luteinizing hormone and prostaglandin E. J Cyclic Nucleotide Res 3:69-83
200. Eckstein B, Greenbaum O, Cohen S 1985 Kinetic studies on ovarian C-l 7, 20-lyase activity: effect of luteinizing hormone surge. Endocrinology 117:2376-2382
201. Levrant SG, Barnes RB, Rosenfield RL, hCG-stimulated 17, 20-lyase activity is unaffected by tamoxifen in PCOS or normal subjects. Program of the 76th Annual Meeting of The Endocrine Society, Anaheim, CA, 1994 (Abstract 837)
202. Rosenfield RL, Ehrmann DA, Bames RB, Sheikh Z 1993 Gona-dotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann NY Acad Sci 687:162-181
203. Rani CSS, Payne AH 1986 Adenosine 3’, 5’-monophosphate-mediated induction of 17a-hydroxylase and C17-20 lyase activities in cultured mouse Leydig cells is enhanced by inhibition of steroid biosynthesis. Endocrinology 118:1222-1228
204. Magoffin DA, Kurtz KM, Erickson GF 1990 Insulin-like growth factor-I selectively stimulates cholesterol side-chain cleavage expression in ovarian theca-interstitial cells. Mol Endocrinol 4:489-496
205. Magoffin D, Weitsman SR 1992 Regulation of cholesterol side-chain cleavage and 17a-hydroxylase mRNAs by LH and IGF-I in ovarian thecal-interstitial cells. Program of the 74th Annual Meeting of The Endocrine Society, San Antonio, TX, 1992 (Abstract 121)
206. Ryan KJ, Smith OW 1965 Biogenesis of steroid hormones in the human ovary. Recent Prog Horm Res 21:367-409
207. Axelrod LR, Goldzieher JW 1962 The polycystic ovary. III. Steroid biosynthesis in normal and polycystic ovarian tissue. J Clin Endocrinol 22:431-440
208. Dorfman RI, Forchielli E, Gut M 1963 Androgen biosynthesis and related studies. Recent Prog Horm Res 19:251-273
209. Kase N, Forchielli E, Dorfman RI 1961 In vitro production of testosterone and androst-4-ene-3, 17-dione in a human ovarian ho-mogenate. Acta Endocrinol (Copenh) 37:19-23
210. Fevold HR, Lorence MC, McCarthy JL, Trant JM, Kagimoto M, Waterman MR, Mason JI 1989 Rat P45017α from testis: characterization of a full-length cDNA encoding a unique steroid hydroxylase capable of catalyzing both A4- and A5-steroid-l 7, 20-lyase reactions. Mol Endocrinol 3:968-975
211. Kitamura M, Buczko E, Dufau ML 1991 Dissociation of hydroxylase and lyase activities by site-directed mutagenesis of the rat P45017a. Mol Endocrinol 5:1373-1380
212. Estabrook RW, Mason JI, Martin-Wixtrom C, Zuber M, Waterman MR 1988 Some enzymatic vagaries of a bovine adrenal microsomal cytochrome P-450 introduced and expressed in transformed monkey kidney cells. Prog Clin Biol Res 274:525-540
213. Zuber MX, Simpson ER, Waterman MR 1986 Expression of bovine 17a-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science 234:1258-1261
214. Miller WL 1988 Molecular biology of steroid hormone synthesis. Endocr Rev 9:295-318
215. Nakajin S, Shinoda M, Haniu M, Shively JE, Hall PF 1984 C21 steroid side chain cleavage enzyme from porcine adrenal micro-somes. J Biol Chem 259:3971-3976
216. Lin D, Chiao E, Miller WL, Computerized construction and mutational analysis in COS-1 cells of a model for the active site of human P450cl7. Program of the 74th Annual Meeting of The Endocrine Society, San Antonio, TX, 1992 (Abstract 588)
217. Lieberman S, Prasad WK 1990 Heterodox notions on pathways of steroidogenesis. Endocr Rev 11:469-493
218. Jefcoate CE, McNamara BC, DiBarolomeis MJ 1986 Control of steroid synthesis in adrenal fasciculata cells. Endocr Res 12:315-350
219. Yanase T, Sanders D, Shibata A, Matsui N, Simpson ER, Waterman MR 1990 Combined 17a-hydroxylase/17, 20-lyase deficiency due to a 7-basepair duplication in the N-terminal region of the cytochrome P450cl7a (CYP17) gene. J Clin Endocrinol Metab 70: 1325-1329
220. Cooke GM, Robaire B 1988 Phospholipases modulate the rat testicular androgen biosynthetic pathway in vitro. Biol Reprod 39: 329-339
221. Rich BH, Rosenfield RL, Lucky AW, Helke JC, Otto P 1981 Adre-narche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab 52:1129-1134
222. Dickerman Z, Grant DR, Faiman C, Winter JSD 1984 Intraadrenal steroid concentrations in man: zonal differences and developmental changes. J Clin Endocrinol Metab 59:1031-1036
223. Brinkmann A, Leemborg I, Rommarts F, van der Molen H 1982 Translocation of the testicular estradiol receptor is not an obligatory step in the gonadotropin-induced inhibition of C-l 7, 20-lyase. Endocrinology 110:1834-1836
224. Nozu K, Dehejia A, Zawistowich L, Catt KJ, Dufau ML 1981 Gonadotropin-induced receptor regulation and steroidogenic lesions in cultured Leydig cells. J Biol Chem 256:12875-12882
225. Onoda M, Hall PF 1981 Inhibition of testicular microsomal cytochrome P-450 (17a-hydroxylase/C-17, 20-lyase) by estrogens. Endocrinology 109:763-767
226. Magoffin DA, Erickson GF 1981 Mechanism by which 17β-estradiol inhibits ovarian androgen production in the rat. Endocrinology 108:962-969
227. Magoffin DA, Erickson GF 1982 Direct inhibitory effect of estrogen on LH-stimulated androgen synthesis by ovarian cells cultured in defined medium. Mol Cell Endocrinol 28:81-89
228. Jones TM, Fang VS, Landau RL, Rosenfield RL 1978 Direct inhibition of Leydig cell function by estradiol. J Clin Endocrinol Metab 47:1368-1373
229. Iwai T, Nanbu Y, Iwai M, Taii S, Fujii S, Mori T 1990 Immuno-histochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle. Virchows Arch [A] 417:369-375
230. Dierschke DJ, Chaffin CL, Hutz RJ 1994 Role and site of estrogen action in follicular atresia. Trends Endocrinol Metab 5:215-219
231. Billiar RB, Loukides JA, Miller MM 1992 Evidence for the presence of the estrogen receptor in the ovary of the baboon (Papio anubis). J Clin Endocrinol Metab 75:1159-1165
232. Adashi EY, Hsueh AJW 1981 Autoregulation of androgen production in a primary culture of rat testicular cells. Nature 293: 737-738
233. Hales DB, Sha L, Payne AH 1987 Testosterone inhibits cAMP-induced de novo synthesis of Leydig cell cytochrome P-45017a by an androgen receptor-mediated mechanism. J Biol Chem 262:11200-11206
234. Simone DA, Chorich LP, Mahesh VB 1993 Mechanisms of action for an androgen-mediated autoregulatory process in rat thecal-interstitial cells. Biol Reprod 49:1190-1201
235. Jones TM, Fang VS, Landau RL, Rosenfield RL 1977 The effects of fluoxymesterone administration on testicular function. J Clin Endocrinol Metab 44:121-129
236. Hild-Petito S, West NB, Brenner RM, Stouffer RL 1991 Localization of androgen receptor in the follicle and corpus luteum of the primate ovary during the menstrual cycle. Biol Reprod 44:561-568
237. Harrison LC, Dean B, Peluso I, Clark S, Ward G 1985 Insulin resistance, acanthosis nigricans, and polycystic ovaries associated with a circulating inhibitor of postbinding insulin action. J Clin Endocrinol Metab 60:1047-1052
238. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J 1976 The syndromes of insulin resistance and acanthosis nigricans. N Engl J Med 294:739-742
239. Bar RS, Muggeo M, Roth J, Kahn KR, Havrankova J, Imperato-McGinley J 1978 Insulin resistance, acanthosis nigricans, and normal insulin receptors in a young woman: evidence for a postreceptor defect. J Clin Endocrinol Metab 47:620-625
240. Taylor SI, Dons RF, Hernandez E, Roth J, Gorden P 1982 Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. Ann Intern Med 97:851-855
241. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ 1986 Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 62:904-910
242. Bergh C, Carlsson B, Olssonn J-H, Selleskogn U, Hillensjon T 1993 Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril 59: 323-331
243. Poretsky L, Smith D, Seibel M, Pazians A, Moses AC, Flier JS 1984 Specific insulin binding sites in human ovary. J Clin Endocrinol Metab 59:809-811
244. Poretsky L, Grigorescu F, Seibel M, Moses AC, Flier JS 1985 Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary. J Clin Endocrinol Metab 61:728-734
245. Jarrett II JC, Ballejo G, Tsibris JCM, Spellacy WN 1985 Insulin binding to human ovaries. J Clin Endocrinol Metab 60:460-463
246. El-Roeiy A, Chen X, Roberts VJ, Shimasaki S, Ling N, LeRoith D, Roberts Jr CT, Yen SS 1994 Expression of the genes ecoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 78:1488-1496
247. Poretsky L, Bhargava G, Levitan E 1990 Type I insulin-like growth factor receptors in human ovarian stroma. Horm Res 33:22-26
248. McClain DA 1991 Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 5:734-739
249. Yamaguchi Y, Flier J, Yokota A, Benecke H, Backer J, Moller DE 1991 Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology 129:2058-2066
250. Siddle K, Soos MA, Field CE, Navé BT 1994 Hybrid and atypical insulin/insulin-like growth factor I receptors. Horm Metab Res 41 [Suppl 2]:56-65
251. Frattali AL, Pessin JE 1993 Molecular defects of insulin/IGF-1 receptor transmembrane signalling. Ann NY Acad Sci 687:77-89
252. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG 1991 A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83-89
253. Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, Franks S 1992 Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36:105-111
254. Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, Blackard WG 1989 Suppression of serum insulin levels by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68: 1027-1032
255. Rosenfield RL 1975 Studies of the relation of plasma androgen levels to androgen action in women. J Steroid Biochem 6:695-702
256. Poretsky L 1991 On the paradox of insulin-induced hyperandrogenism in insulin resistant states. Endocr Rev 12:3-13;
257. Hernandez ER, Hurwitz A, Vera A, Pellicer A, Adashi EY, Leroith D, Roberts Jr CT 1992 Expression of the genes encoding the insulinlike growth factors and their receptors in the human ovary. J Clin Endocrinol Metab 74:419-425 (erratum in J Clin Endocrinol Metab 1993;76:1343)
258. Poretsky L, Bhargava G, Kalin MF, Wolf SA 1988 Regulation of insulin receptors in the human ovary: in vitro studies. J Clin Endocrinol Metab 67:774-778
259. Laatikainen T 1993 How IGF-1 and IGF-1 binding protein can be modulated in polycystic ovarian syndrome. Ann NY Acad Sci 687:90-97
260. Slowinska-Srzednicka J, Zgliczynski W, Makowska A, Jeske W, Brzezinska A, Soszynski P, Zgliczynski S 1992 An abnormality of the growth hormone/insulin-like growth factor-1 axis in women with polycystic ovary syndrome due to coexistent obesity. J Clin Endocrinol Metab 74:1432-1435
261. Zhou J, Bondy C 1993 Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod 48:467-482
262. Adashi EY 1993 Intraovarian regulation: the proposed role of insulin-like growth factors. Ann NY Acad Sci 687:10-12
263. Hernandez ER, Resnick CE, Svoboda ME, Van Wyck JJ, Payne DW, Adashi EY 1988 Somatomedin-C/Insulin-like growth factor I as an enhancer of androgen biosynthesis by cultured rat ovarian cells. Endocrinology 122:1603-1612
264. Hernandez ER, Roberts CT, LeRoith D, Adashi EY 1989 Rat ovarian insulin-like growth factor (IGF-I) gene expression is granulosa cell-selective: 5’-untranslated mRNA variant representation and hormonal regulation. Endocrinology 125:572-574
265. Magoffin DA, Weitsman SR 1993 Differentiation of ovarian theca-interstitial cells in vitro: regulation of 17a-hydroxylase messenger ribonucleic acid expression by luteinizing hormone and insulinlike growth factor-I. Endocrinology 132:1945-1951
266. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ 1991 Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol Cell Endocrinol 75:R1-R6
267. Voutilainen R, Miller WL 1987 Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450 ssc, in human steroidogenic tissues. Proc Natl Acad Sci USA 84:1590-1594
268. Adashi EY, Resnick CE, Rosenfeld R 1990 Insulin-like growth factor I (IGF-I) and IGF-II hormonal action in cultured rat granulosa cells: mediation via type I but not type II IGF receptors. Endocrinology 126:216-222
269. Hernandez ER, Hurwitz A, Botero L, Ricciarelli E, Werner H, Roberts Jr CT, Leroith D, Adashi EY 1991 Insulin-like growth factor receptor gene expression in the rat ovary: divergent regulation of distinct receptor species. Mol Endocrinol 5:1799-1805
270. Allen WR, Nilsen-Hamilton M, Hamilton RT 1981 Insulin and growth factors stimulate rapid posttranslational changes in glucose transport in ovarian granulosa cells. J Cell Physiol 108:15-24
271. Hsueh A, Adashi EY, Jones PB, Welsh THJ 1984 Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocr Rev 5:76-127
272. Adashi EY, Resnick CE, D’Ercole AJ, Svoboda ME, VanWyk JJ 1985 Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev 6:400-420
273. Lessman CA, Schuetz AW 1981 Role of follicle wall in meiosis reinitiation induced by insulin in Rana pipiens oocytes. Am J Physiol 241:E51-E56
274. Bergh C, Carlsson B, Olsson J-H, Billig H, Hillensjo T 1991 Effects of insulin-like growth factor and growth hormone in cultured human granulosa cells. Ann NY Acad Sci 626:169-176
275. Urdl W, Desoye G, Schmon B, Hofmann HMH, Ralph G 1991 Interactions between insulin and insulin-like growth factor I in the pathogenesis of polycystic ovarian disease. Ann NY Acad Sci 626: 177-183
276. Cataldo NA, Guidice LC 1992 Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status. J Clin Endocrinol Metab 74:821-829
277. Cataldo NA, Guidice LC 1992 Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome. J Clin Endocrinol Metab 74:695-698
278. Dor J, Costritsci N, Pariente C, Rabinovici J, Mashiach S, Lunen-feld B, Kaneti H, Seppala M, Koistinen R, Karasik A 1992 Insulinlike growth factor-I and follicle-stimulating hormone suppress insulin-like growth factor binding protein-1 secretion by human granulosa luteal cells. J Clin Endocrinol Metab 75:969-973
279. Nemeth G, Pepperell JR, Yamada Y, Palumbo A, Naftolin F 1994 The basis and evidence of a role for the ovarian renin-angiotensin system in health and disease. J Soc Gynecol Invest 1:118-127
280. Leung PCK, Steele GL 1992 Intracellular signaling in the gonads. Endocr Rev 13:476-498
281. Barria A, Leyton V, Ojeda SR, Lara HE 1993 Ovarian steroidal response to gonadotropins and /3-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology 133:2696-2703
282. Hurwitz A, Loukides J, Ricciarelli E, Botero L, Katz E, McAllister JM, Garcia JE, Rohan R, Adashi EY, Hernandez ER 1992 Human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist. J Clin Invest 89: 1746-1754
283. McAllister JM, Byrd W, Simpson ER 1994 The effects of growth factors and phorbol esters on steroid biosynthesis in isolated human theca interna and granulosalutein cells in long term culture. J Clin Endocrinol Metab 79:106-112
284. Yoshimura Y, Iwashita M, Karube M, Oda T, Akiba M, Shiokawa S, Ando M, Yoshinaga A, Nakamura Y 1994 Growth hormone stimulates follicular development by stimulating ovarian production of insulin-like growth factor-I. Endocrinology 135:887-894
285. Katz E, Ricciarelli E, Adashi EY 1993 The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril 59:8-34
286. Bicsak TA, Tucker EM, Cappel S, Vaughan J, Rivier J, Vale W, Hsueh AJW 1986 Hormonal regulation of granulosa cell inhibin biosynthesis. Endocrinology 119:2711-2719
287. Rabinovici J, Spencer SJ, Doldi N, Goldsmith PC, Schwall R, Jaffe RB 1992 Activin-A as an intraovarian modulator: actions, localization, and regulation of the intact dimer in human ovarian cells. J Clin Invest 89:1528-1536
288. Ying SY 1988 Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9:267-293
289. Woodruff TK, Lyon RJ, Hansen SE, Rice GC, Mather JP 1990 Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology 127:3196-3205
290. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall R, Mason AJ 1991 Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J Clin Endocrinol Metab 72:1206-1211
291. Hsueh AJW, Dahl KD, Vaughan J, Tucker E, Rivier J, Bardin CW, Vale W 1987 Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci USA 84:5082-5086
292. Cameron VA, Nishimura E, Mathews LS, Lewis KA, Sawchenko PE, Vale WW 1994 Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology 134:799-808
293. Smyth CD, Miro F, Whitelaw PF, Howies CM, Hillier SG 1993 Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology 133:1532-1538
294. Derynck R 1988 Transforming growth factor-a. Cell 54:593-595
295. Chegini N, Williams RS 1992 Immunocytochemical localization of transforming growth factors (TGFs) TGF-a and TGF-β in human ovarian tissues. J Clin Endocrinol Metab 74:973-980
296. Mason HD, Leake RE, Carr L, Franks S, Production of transforming growth factor-alpha by normal and polycystic human ovaries. Program of the 73rd Annual Meeting of The Endocrine Society, Washington, D.C., 1991 (Abstract 1664)
297. Bendell JJ, Dorrington JH 1990 Epidermal growth factor influences growth and differentiation of rat granulosa cells. Endocrinology 127:533-540
298. Mason HD, Margara R, Winston RML, Beard RW, Reed MJ, Franks S 1990 Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal and polycystic ovaries. Clin Endocrinol (Oxf) 33:511-517
299. Roy SK, Harris SG 1994 Antisense epidermal growth factor oli-godeoxynucleotide inhibits follicle-stimulating-hormone-induced in vitro DNA and progesterone synthesis in hamster preantral follicles. Mol Endocrinol 8:1175-1181
300. Weitzman SR, Magoffin DA 1993 Transforming growth factor-a inhibits luteinizing hormone-stimulated androgen production by blocking 17a-hydroxylase/C-17, 20-lyase activity in ovarian theca-interstitial cells. Endocrine J 1:109-115
301. Bendell JJ, Dorrington J 1988 Rat theca interstitial cells secrete a transforming growth factor beta like factor that promotes growth and differentiation in rat granulosa cells. Endocrinology 123: 941-948
302. Adashi EY, Resnick CE, Hernandez ER, May JV, Purchio AF, Twardzik DR 1989 Ovarian transforming growth factor-j3 (TGFβ): cellular site(s), and mechanism(s) of action. Mol Cell Endocrinol 61:247-256
303. Hernandez ER, Hurwitz A, Payne DW, Kharmarjan AM, Purchio AF, Adashi EY 1990 Transforming growth factor-β1 inhibits ovarian androgen production: gene expression, cellular localization, mechanism(s) and site(s) of action. Endocrinology 127:2804-2811
304. Rainey WE, Naville D, Saez JM, Carr BR, Byrd W, Magness RR, Mason JI 1990 Transforming growth factor-β inhibits 17α-hydrox-ylase cytochrome P450 expression in ovine adrenocortical cells. Endocrinology 127:1910-1915
305. Roby KF, Terranova PF 1990 Effects of tumor necrosis factor-a in vitro on steroidogenesis of healthy and atretic follicles of the rat: theca as a target. Endocrinology 126:2711-2718
306. Roby KF, Terranova PF 1990 Immunological evidence for a human ovarian tumor necrosis factor-a. J Clin Endocrinol Metab 71: 1096-1102
307. Hotamisligil GS, Shargill NS, Spiegelman B M 1993 Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 259:87-91
308. Ross GT, Cargille CM, Lipsett MB, Rayford PL, Marshall JR, Strott CA, Rodbard D 1970 Pituitary and gonadal hormones in women during spontaneous and individual ovulatory cycles. Recent Prog Horm Res 26:1-62
309. Hemrika DJ, Slaats EH, Kennedy JC, De-Vries-Robles-Korsen TJ, Schoemaker J 1993 Pulsatile luteinizing hormone patterns in long term oral contraceptive users. J Clin Endocrinol Metab 77:420-426
310. O’Meara N, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL, Polonsky KS 1993 Defects in beta cell function and insulin action in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1241-1247
311. Burstein S, Schaff-Blass E, Blass J, Rosenfield RL 1985 The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab 61: 508-513
312. Fauser BCJM, Pache TD, Lamberts SWJ, Hop WCJ, de Jong FH, Dahl KD 1991 Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J Clin Endocrinol Metab 73:811-817
313. Imse V, Holzapfel G, Hinney B, Kuhn W, Wuttke W 1992 Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays. J Clin Endocrinol Metab 74:1053-1061
314. Chang SP, Shoupe D, Kletzky OA, Lobo RA 1984 Differences in the ratio of bioactive to immunoreactive serum luteinizing hormone during vasomotor flushes and hormonal therapy in postmenopausal women. J Clin Endocrinol Metab 58:925-929
315. Dunaif A, Graf M 1989 Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest 83:23-29
316. Kratochwil A, Urban G, Friedrich F 1972 Ultrasonic tomography of the ovaries. Ann Chir Gynaecol Fenn 61:211-214
317. Saxton DW, Farquhar CM, Rae T, Beard RW, Anderson MC, Wadsworth J 1990 Accuracy of ultrasound measurements of female pelvic organs. Br J Obstet Gynaecol 97:695-699
318. Adams J, Franks S, Poison DW, Mason HD, Abdulwahid NA, Tucker M, Morris DV, Price J, Jacobs HS 1985 Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet 2:1375-1378
319. Hann LE, Hall DA, McArdle CR, Seibel M 1984 Polycystic ovarian disease: sonographic spectrum. Radiology 150:531-534
320. Parisi L, Tramonti M, Derchi LE, Casciano S, Zurli A, Rocchi P 1984 Polycystic ovarian disease: ultrasonic evaluation and correlations with clinical and hormonal data. J Clin Ultrasound 12:21-26
321. Poison DW, Adams J, Wadsworth J, Franks S 1988 Polycystic ovaries—a common finding in normal women. Lancet 1:870-872
322. Tabbakh GH, Lotfy I, Azab I, Rahman HA, Southren AL, Aleem FA 1986 Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings. Am J Obstet Gynecol 154:892-895
323. Yeh HC, Futterweit W, Thornton JC 1987 Polycystic ovarian disease: US features in 104 patients. Radiology 163:111-116
324. Timor-Tritsch IE, Rottem S (eds) 1988 Transvaginal Sonography. Elsevier Science Publishing Co., Inc., New York
325. Nicolini U, Ferrazzi E, Bellotti M, Travaglini P, Elli R, Scaperrotta RC 1985 The contribution of sonographic evaluation of ovarian size in patients with polycystic ovarian disease. J Ultrasound Med 4:347-351
326. Pache TD, Chada S, Gooren LJG, Hop WCJ, Jaarsma KW, Dommerholt HBR, Fauser BCJM 1991 Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology 19:445-452
327. Futterweit W, Yeh HC, Thornton 1987 Lack of correlation of ultra-sonographically determined ovarian size with age, ponderal index, and hormonal factors in 45 patients with polycystic ovarian disease. Int J Fertil 32:456-459
328. Dewailly D, Duhamel A, Robert Y, Ardaens Y, Beuscart R, Lemaitre L, Fossati P 1993 Interrelationship between ultrasonography and biology in the diagnosis of polycystic ovarian syndrome. Ann NY Acad Sci 687:206-216
329. Mulaikal RM, Migeon CJ, Rock JA 1987 Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 316:178-182
330. Steinberger E, Rodriguez-Rigau LJ, Weidman ER, Smith KD, Ayala C 1990 Glucocorticoid therapy in hyperandrogenism. Ballieres Clin Obstet Gynaecol 4:457-471
331. Lachelin GCL, Barnett M, Hopper BR Brink G, Yen SSC 1979 Adrenal function in normal women and women with the polycystic ovary syndrome. J Clin Endocrinol Metab 49:892-899
332. Lucky AW, Rosenfield RL, McGuire J, Rudy S, Helke J 1986 Adrenal androgen hyperresponsiveness to ACTH in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab 62:840-848
333. Lobo RA, Goebelsmann U 1981 Evidence for a reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome. J Clin Endocrinol Metab 53:394-400
334. Azziz R, Bradley EL, Potter HD, Boots LR 1993 3β-hydroxysteroid dehydrogenase deficiency in hyperandrogenism. Am J Obstet Gynecol 168:889-895
335. Chang YT, Zhang L, Mason JI Murray BA, Wang J, Lin K, Garibaldi LR, Bourdney C, Pang S 1994 Redefining hormonal criteia for mild 3β-hydroxysteroid dehydrogenase (3β-HSD) deficiency (def) congenital adrenal hyperplasia. Pediatr Res 35 (part 2):96A (Abstract 563)
336. Zerah M, Rhéaume E, Mani P, Schram P, Simard J, Labrie F, New MI 1994 No evidence of mutations in the genes for type I and II 3β-hydroxysteroid dehydrogenase (3βHSD) in nonclassical 3βHSD deficiency. J Clin Endocrinol Metab 79:1811-1817
337. Mathieson J, Couzinel B, Wekstein-Noel S, Nahout K, Turpin G, Schalson G 1992 The incidence of late-onset congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency among hirsute women. Clin Endocrinol (Oxf) 36:383-388
338. Barnes RL, Ehrmann DA, Brigell DF, Rosenfield RL 1993 Ovarian steroidogenic responses to the gonadotropin-releasing hormone agonist nafarelin in hirsute women thought to have 3β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 76: 450-455
339. Azziz R, Bradley EJ, Potter H, Boots L 1995 Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17, 20-lyase dysregulation. J Clin Endocrinol Metab 80:400-405
340. Ditkoff E, Fruzzetti F, Chang L, Stancyzk F, Lobo R 1995 The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome. J Clin Endocrinol Metab 80: 603-607
341. Turner EI, Watson MJ, Perry LA, White MC 1992 Investigation of adrenal function in women with oligomenorrhoea and hirsutism (clinical PCOS) from the north-east of England using an adrenal stimulation test. Clin Endocrinol (Oxf) 36:389-397
342. Porter B, Finzi M, Lieberman E, Moses S 1977 The syndrome of congenital adrenal hyperplasia in Israel. Paediatrician 6:100-105
343. Azziz R, Owerbach D 1995 Molecular abnormalities of the 21- hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation. Am J Obstet Gynecol 172:914-918.
344. Young J, Couzinet B, Pholsena M, Nahoul K, Labrie F, Schaison G 1994 Plasma 3β-hydroxy-A5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 78:299-304
345. Dewailly D, Vantyghem MC, Lemaire C, Dufosse F, Racadot A, Fossati P 1988 Screening heterozygotes for 21-hydroxylase deficiency among hirsute women: lack of utility of the adrenocortico-tropin hormone test. Fertil Steril 50:228-232
346. Rodin A, Thakkar H, Taylor N, Clayton R 1994 Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N Engl J Med 330:460-465
347. Mowszowicz I, Melanitou E, Kirckhoffer MD, Mauvais-Jarvis P 1983 Dihydrotestosterone stimulates 5a-reductase activity in pubic skin fibroblasts. J Clin Endocrinol Metab 56:320-325
348. Leenen R, van der Kooy K, Seidell JC, Deurenberg P, Koppe-schaar HP 1994 Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 78:1515-1520
349. Komindr S, Kurtz BR, Stevens MD, Karas JG, Bittle JB, Givens JR 1986 Relative sensitivity and responsivity of serum cortisol and two adrenal androgens to adrenocorticotropin-(l-24) in normal and obese, nonhirsute, eumenorrheic women. J Clin Endocrinol Metab 63:860-864
350. Farah MJ, Givens J, Kitabchi AE 1990 Bimodal correlation between the circulating insulin level and the production rate of dehydro-epiandrosterone: positive correlation in controls and negative correlation in the polycystic ovary syndrome with acanthosis nigricans. J Clin Endocrinol Metab 70:1075-1081
351. Stuart DA, Nagamani M 1992 Acute augmentation of plasma androstenedione and dehydroepiandrosterone by euglycemic insulin infusion: evidence for a direct effect of insulin on ovarian steroidogenesis. In: Dunaif A, Givens J, Haseltine F, Merriam G (eds) Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Blackwell Scientific, Cambridge, MA
352. Micic D, Popovic V, Nesovic M, Sumarac M, Dragasevic M, Kendereski A, Markovic D, Djordjevic P, Manojlovic D, Micic J 1988 Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease. J Steroid Biochem 31:995-999
353. Nestler JE, Clore JN, Strauss III JF, Blackard WG 1987 The effects of hyperinsulinemia on serum testosterone, progesterone, de-hydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 64: 180-184
354. Nestler JE, McClanahan MA, Clore JN, Blackard WG 1992 Insulin inhibits adrenal 17, 20-lyase activity in man. J Clin Endocrinol Metab 74:549-554
355. Nestler JE, Beer NA, Jakubowicz DJ, Beer RM 1994 Effects of a reduction in circulating insulin by metformin on serum dehydro-epiandrosterone sulfate in nondiabetic men. J Clin Endocrinol Metab 78:549-554
356. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and sytolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43:647-654
357. Sonnenberg GE, Hoffman RG, Mueller RA, Kissebah AH 1994 Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity. Diabetes 43:468-477
358. Kissebah AH 1992 Upper body obesity: abnormalities in the metabolic profile and the androgenic/estrogenic balance. In: Dunaif A, Givens J, Haseltine F, Merriam G (eds) Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Blackwell Scientific, Cambridge, MA
359. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and/or hyperinsulinemia. J Clin Endocrinol Metab 65:499-507
360. Dunaif A 1992 Diabetes mellitus and polycystic ovary syndrome. In: Dunaif A, Givens J, Haseltine F, Merriam G (eds) Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome. Blackwell Scientific, Cambridge, MA
361. Ovesen P, Moller J, Ingerslev HJ, Jorgensen JOL, Mengel A, Schmitz O, Alberti KGMM, Moller N 1993 Normal basal and insulin-stimulated fuel metabolism in lean women with polycystic ovary syndrome. J Clin Endocrinol Metab 77:1636-1640
362. Rajkowa M, Bicknell J, Jones M, Clayton RN 1994 Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia. Fertil Steril 61:605-612
363. Bjomtorp P 1990 Classification of obese patients and complications related to the distribution of surplus fat. Nutrition 6:131-137
364. Robinson S, Chan S-P, Spacey S, Anyaoku V, Johnston DG, Franks S 1992 Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol (Oxf) 36:537-543
365. Segal KR, Dunaif A 1990 Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome. Int J Obes 14: 559-567
366. Burghen GA, Givens JR, Kitabchi AE 1980 Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J Clin Endocrinol Metab 50:113-116
367. Shoupe D, Kumar DD, Lobo RA 1983 Insulin resistance in polycystic ovarian syndrome. Am J Obstet Gynecol 147:588-592
368. Azziz R, Deal CL, Potter HD, Gargosky SE, Rosenfeld RG 1994 Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women. J Clin Endocrinol Metab 79:1747-1751
369. Weiss DJ, Charles MA, Dunaif A, Prior DE, Lillioja S, Knowler WC, Herman WH 1994 Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women. Metabolism 43:803-807
370. Flier JS, Moller DE, Moses AC, O’Rahilly S, Chaiken RL, Grigorescu F, Elahi D, Kahn BB, Weinreb JE, Eastman R 1993 Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resisitance. J Clin Endocrinol Metab 76:1533-1541
371. Prelevic GM, Wurzburger MI, Balint-Peri CL, Nesic JS 1990 Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome. Lancet 336: 900-903
372. Kuzuya H, Matsuura N, Sakamoto M, Makino H, Sakamoto Y, Kadowaki T, Suzuki Y, Kobayashi M, Akazawa Y, Nomura M Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 42:696-705
373. Rheinwald JG, Green H 1977 Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 265:421-424
374. Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W, Lewy L 1991 Acanthosis nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. J Clin Endocrinol Metab 73:590-595
375. Annos T, Taymor ML 1981 Ovarian pathology associated with insulin resistance and acanthosis nigricans. Obstet Gynecol 58: 662-664
376. Givens JR, Kerber IJ, Wiser WL, Andersen RN, Coleman SA, Fish SA 1974 Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma. J Clin Endocrinol Metab 38:347-355
377. Nagamani M, Dinh TV, Kelver ME 1986 Hyperinsulinemia in hyperthecosis of the ovaries. Am J Obstet Gynecol 154:384-389
378. Billiar RB, Richardson D, Schwartz R, Posner B, Little B 1987 Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus monkeys. Am J Obstet Gynecol 157:1297-1302
379. Polderman KH, Gooren LJG, Asscheman H, Bakker A, Heine RJ Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79:265-271
380. Shoupe D, Lobo RA 1984 The influence of androgens on insulin resistance. Fertil Steril 41:385-388
381. Cole C, Kitabchi AE 1978 Remission of insulin resistance with Ortho-Novum in a patient with polycystic ovarian disease and acanthosis nigricans. Clin Res 26 (Abstract)
382. Speiser PW, Serrat J, New MI, Gertner JM 1992 Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 75:1421-1424
383. Abbott DH, Eisner JR, Kennitz JW, Baum ST, Dumesic DA Increased adiposity is associated with ovarian dysfunction in prenatally androgenized female Rhesus monkeys. Program of the 76th Annual Meeting of The Endocrine Society, Anaheim, CA, 1994 (Abstract 451)
384. Dunaif A 1993 Insulin resistance in polycystic ovarian syndrome. Ann NY Acad Sci 687:60-64
385. Harris MI, Hadden WC, Knowler WC, Bennett PH 1987 Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36: 523-534
386. King H, Rewers M 1993 Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157-177
387. Dahlgren E, Lapidus L, Janson PO, Lindstedt G, Johansson S, Tengbom L 1994 Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril 61:455-460
388. Dahlgren E, Johansson S, Linstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N, Lundberg PA 1992 Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a longterm follow-up focusing on natural history and circulating hormones. Fertil Steril 57:505-513
389. Dunaif A 1992 Insulin resistance and ovarian hyperandrogenism. The Endocrinologist 2:248-260
390. Polonsky KS, Given BD, Hirsch L, Tillil H, Shapiro ET, Beebe C, Frank BH, Galloway JA, van Cauter E 1988 Abnormal patterns of insulin secretion in non-insulin dependent diabetes. N Engl J Med 318:1231-1239
391. Bergman RN, Phillips LS, Cobelli C 1981 Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467
392. Holte J, Bergh T, Berne C, Berglund L, Lithell H 1994 Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab 78:1052-1058
393. Dunaif A, Green G, Finegood D, Pancreatic beta (B) cell function is normal in insulin resistant women with the polycystic ovary syndrome (PCOS). Program of the 74th Annual Meeting of The Endocrine Society, San Antonio, TX, 1992 (Abstract 280)
394. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP 1993 Quantification of the relationship between insulin sensitivity and B-cell function in human subjects Evidence for a hyperbolic function. Diabetes 42:1663-1672
395. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS, Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin dependent diabetes mellitus. J Clin Invest, in press
396. Sturis J, Van Cauter E, Blackman JD, Polonsky KS 1991 Entrain-ment of pulsatile insulin secretion by oscillatory glucose infusion. J Clin Invest 87:435-439
397. O’Meara NM, Sturis J, Van Cauter E, Polonsky KS 1993 Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest 92:262-271